Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Consumer Drugs

Set Alert for Consumer Drugs

Perrigo CEO Takes Faith In Rx Generics Business To Exit Door With Him

Private label OTC business is likely to be strengthened as Perrigo’s core, as CEO Hendrickson announces retirement shortly after hedge fund investor Starboard Value, pushing to divest the Rx business, built a five-seat block on Perrigo's board.

Consumer Prescription To Otc Switch Consumer

Latest From Consumer

Perrigo Predicts Upturn On OTC Private Label Breadth, Depth And Bandwidth

Perrigo counts on its OTC private label dominance to thwart new store brand entries and give it a leg-up in e-commerce sales, which are growing at 50% year-to-year. Private label is "a distinctly different business than the national brand space," says consumer health executive Jeffrey Needham.

Consumer Prescription To Otc Switch

Oral Contraceptive Switch Advocates Reject User Age As Approval Factor

FDA could soon receive an NDA from non-profit research group Ibis Reproductive Health and HRA Pharma, for an oral contraceptive switch in the US.

Prescription To Otc Switch Consumer

States Ease Access To Oral Contraceptives Despite Rx Requirement

Changes range from allowing pharmacists to prescribe the drugs to requiring insurers to insurers to cover purchases of the products.

Prescription To Otc Switch Consumer

OTC Sleep Aid Sales Snooze As Consumers Wake Up To Alternatives

Natural products cut into sales of OTC sleep aids as more consumers prefer naturals as non-addictive and not causing grogginess the following day, Kline & Co. research shows. OTC sleep aids posted 3.4% growth in 2016, down from 50% to 15% growth in recent years.

Consumer Dietary Supplements

P&G Could Lean Toward OTC Brand Sales With Activist Investor Influence

Analysts consider the potential for P&G splitting up or selling OTC or beauty care assets following CEO David Taylor's recent comments on possible moves with activist investor Trian. Analysts weigh in on the potential for sale or swap of brands and whether the moves would help.

Consumer M & A

Consumer Health Weekly Trademark Review June 6, 2017

Class 3 (Cosmetics and Cleaning Preps) and Class 5 (Pharmaceuticals) compiled from the Official Gazette of the U.S. Patent and Trademark Office.

Consumer Trademarks
See All